Clinical Trial

Testing Experimental Medication in Healthy Subjects

Study Description

Phase 1 Study to Assess AER-271

The objective of this Phase 1 trial is to assess the safety, tolerability and pharmacokinetics of AER-271 in health subjects.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - AER-271

AER-271, the test article for this study.

Drug - Placebo

Placebo control for this study.

Additional Information

Official Study Title

A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Sequential-Group Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of AER-271 in Healthy Subjects

Clinical Trial ID

NCT03804476

ParticipAid ID

eER1Ka